Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|February 10, 2024
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123Serena Zanotta, Domenico Galati, Rosaria De Filippi, et al.
International Journal of Molecular Sciences|July 27, 2024
Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSerena Zanotta, Domenico Galati, Rosaria De Filippi, et al.
Critical Reviews in Oncology/Hematology|December 10, 2016
Dendritic cells in hematological malignanciesDomenico Galati, Gaetano Corazzelli, Rosaria De Filippi, et al.
Molecular Immunology|August 25, 2009
TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathwayAlfonso Lavorgna, Rosaria De Filippi, Silvestro Formisano, et al.
The Journal of Pathology|June 8, 2010
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escapeDonatella Aldinucci, Annunziata Gloghini, Antonio Pinto, et al.
Critical Reviews in Oncology/Hematology|October 18, 2003
Aging and the hemopoietic systemAntonio Pinto, Rosaria De Filippi, Ferdinando Frigeri, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2021
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?Domenico Galati, Serena Zanotta, Marialuisa Bocchino, et al.
Infectious Agents and Cancer|August 12, 2024
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantationRosaria De Filippi, Gianpaolo Marcacci, Sabrina Amelio, et al.
International Journal of Molecular Sciences|March 27, 2025
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell NeoplasmDomenico Galati, Serena Zanotta, Fabrizia Florio, et al.
British Journal of Haematology|November 15, 2018
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphomaDomenico Galati, Serena Zanotta, Gaetano Corazzelli, et al.
Pageof 5